Robert L. Avery

14.0k citations
78 papers · 9.7k · 9 hit papers · h-index 32

Impact in

Papers in

    • Retinal Diseases and Treatments 43
    • Retinal and Optic Conditions 12
    • Intraocular Surgery and Lenses 8
    • Ocular Diseases and Behçet’s Syndrome 6
    • Ocular Infections and Treatments 4
    • Retinal and Macular Surgery 14
    • Retinal Imaging and Analysis 9

Robert L. Avery

77 papers receiving 9.3k citations

Robert L. Avery's Hit Papers

Gene therapy for neovascular age-related macular degeneration by subretinal delivery of RGX-314: a phase 1/2a dose-escalation study 2024 · 59 citations
590+10+21Years since publication10002.0k3.0k

Peers

Robert L. Avery
Comparison fields: 5 of 114
  • Ophthalmology 6.3k
  • Radiology, Nuclear Medicine and Imaging 3.0k
  • Clinical Biochemistry 213
  • Molecular Biology 2.2k
  • Cancer Research 363
Replace Lloyd M. Aiello with:
Lloyd M. Aiello United States
Paul G. Arrigg United States
Hitoshi Takagi Japan
Susan B. Bressler United States
Sergio Caballero United States
A.P. Adamis United States
Christopher M. Aderman United States
Sean F. Hackett United States
Izumi Suzuma Japan
Robert L. Avery relative to Lloyd M. Aiello United States Lloyd M. Aiello's profile →
Citations per field
00.5×
Lloyd M. Aiello · 1×
Citations per year

Countries citing papers authored by Robert L. Avery

Since Specialization
Citations

This map shows the geographic impact of Robert L. Avery's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Robert L. Avery with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Robert L. Avery more than expected).

Fields of papers citing papers by Robert L. Avery

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Robert L. Avery. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Robert L. Avery. The network helps show where Robert L. Avery may publish in the future.

Co-authors

The 25 scholars most cited alongside Robert L. Avery, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Robert L. Avery Line = papers co-authored together Robert L. Avery links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown

Showing the 20 most-cited of 78 papers — load more, or switch the sort, to bring in the rest.

#Work
1
Vascular Endothelial Growth Factor in Ocular Fluid of Patients with Diabetic Retinopathy and Other Retinal Disorders
Hit paper breakdown →
19943038
2
Intravitreal Bevacizumab (Avastin) for Neovascular Age-Related Macular Degeneration
Hit paper breakdown →
2006955
3
Vascular endothelial growth factor/vascular permeability factor expression in a mouse model of retinal neovascularization.
Hit paper breakdown →
1995882
4
Intravitreal Bevacizumab (Avastin) in the Treatment of Proliferative Diabetic Retinopathy
Hit paper breakdown →
2006606
5 2007304
6
Systemic pharmacokinetics following intravitreal injections of ranibizumab, bevacizumab or aflibercept in patients with neovascular AMD
Hit paper breakdown →
2014292
7 2006290
8
A bioengineered retinal pigment epithelial monolayer for advanced, dry age-related macular degeneration
Hit paper breakdown →
2018270
9 2007270
10 1996263
11 2006261
12
SYSTEMIC PHARMACOKINETICS AND PHARMACODYNAMICS OF INTRAVITREAL AFLIBERCEPT, BEVACIZUMAB, AND RANIBIZUMAB
Hit paper breakdown →
2017253
13 2007206
14 2014196
15 2015166
16
The real-world efficacy and safety of faricimab in neovascular age-related macular degeneration: the TRUCKEE study – 6 month results
Hit paper breakdown →
2023106
17 201587
18 200883
19 201372
20 201961

About Robert L. Avery

Robert L. Avery is a scholar working on Ophthalmology, Radiology, Nuclear Medicine and Imaging, Molecular Biology, Epidemiology and Neurology, having authored 78 papers that have together received 9.7k indexed citations. Recurring topics across this work include Retinal Diseases and Treatments (43 papers), Retinal and Macular Surgery (14 papers), Retinal and Optic Conditions (12 papers), Retinal Imaging and Analysis (9 papers), Intraocular Surgery and Lenses (8 papers), Ocular Diseases and Behçet’s Syndrome (6 papers), Retinal Development and Disorders (4 papers) and Ocular Infections and Treatments (4 papers). The work is most often cited by research in Ophthalmology (6.3k citations), Radiology, Nuclear Medicine and Imaging (3.0k citations), Clinical Biochemistry (213 citations), Molecular Biology (2.2k citations) and Cancer Research (363 citations). Robert L. Avery has collaborated with scholars based in United States, Switzerland and Ireland. Frequent co-authors include Dante J. Pieramici, Alessandro Castellarin, Ma'an Nasir, Melvin Rabena, Lloyd Paul Aiello, Paul G. Arrigg, Matthew Giust, Henry Jampel, Bruce A. Keyt and Sabera T. Shah. Their work appears in journals such as Retina, Investigative Ophthalmology & Visual Science, Ophthalmology, Ophthalmic surgery, lasers & imaging retina and Eye.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact